These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33306551)

  • 1. Minimal detection of cerebrospinal fluid escape after initiation of antiretroviral therapy in acute HIV-1 infection.
    Handoko R; Chan P; Jagodzinski L; Pinyakorn S; Ubolyam S; Phanuphak N; Sacdalan C; Kroon E; Dumrongpisutikul N; Paul R; Valcour V; Ananworanich J; Vasan S; Spudich S;
    AIDS; 2021 Apr; 35(5):777-782. PubMed ID: 33306551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
    Joseph SB; Kincer LP; Bowman NM; Evans C; Vinikoor MJ; Lippincott CK; Gisslén M; Spudich S; Menezes P; Robertson K; Archin N; Kashuba A; Eron JJ; Price RW; Swanstrom R
    Clin Infect Dis; 2019 Sep; 69(8):1345-1352. PubMed ID: 30561541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study.
    Livelli A; Vaida F; Ellis RJ; Ma Q; Ferrara M; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Sacktor N; Simpson DM; Grant I; Letendre SL;
    Lancet HIV; 2019 Jul; 6(7):e456-e462. PubMed ID: 31208949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very Early Initiation of Antiretroviral Therapy During Acute HIV Infection Is Associated With Normalized Levels of Immune Activation Markers in Cerebrospinal Fluid but Not in Plasma.
    Hellmuth J; Slike BM; Sacdalan C; Best J; Kroon E; Phanuphak N; Fletcher JLK; Prueksakaew P; Jagodzinski LL; Valcour V; Robb M; Ananworanich J; Allen IE; Krebs SJ; Spudich S
    J Infect Dis; 2019 Nov; 220(12):1885-1891. PubMed ID: 30668739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF Inflammation Markers Associated with Asymptomatic Viral Escape in Cerebrospinal Fluid of HIV-Positive Individuals on Antiretroviral Therapy.
    Guha D; Misra V; Yin J; Gabuzda D
    Viruses; 2023 Aug; 15(9):. PubMed ID: 37766236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting.
    Rawson T; Muir D; Mackie NE; Garvey LJ; Everitt A; Winston A
    J Infect; 2012 Sep; 65(3):239-45. PubMed ID: 22522289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects.
    Pérez-Valero I; Ellis R; Heaton R; Deutsch R; Franklin D; Clifford DB; Collier A; Gelman B; Marra C; McCutchan JA; Navis A; Sacktor N; Simpson D; Grant I; Letendre S
    AIDS; 2019 Mar; 33(3):475-481. PubMed ID: 30702516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse of neurosymptomatic cerebrospinal fluid HIV RNA escape.
    Chan TY; Marta M; Rackstraw S
    HIV Med; 2023 Nov; 24(11):1158-1163. PubMed ID: 37487714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study.
    Edén A; Nilsson S; Hagberg L; Fuchs D; Zetterberg H; Svennerholm B; Gisslén M
    J Infect Dis; 2016 Dec; 214(12):1822-1825. PubMed ID: 27683820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.
    Ferretti F; Gisslen M; Cinque P; Price RW
    Curr HIV/AIDS Rep; 2015 Jun; 12(2):280-8. PubMed ID: 25860317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.
    Filippidis P; Damas J; Viala B; Assal F; Nawej Tshikung O; Tarr P; Derfuss T; Oberholzer M; Jelcic I; Hundsberger T; Sacco L; Cavassini M; Du Pasquier R; Darling KEA;
    J Acquir Immune Defic Syndr; 2023 Jul; 93(3):219-228. PubMed ID: 36927958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
    Henrich TJ; Hatano H; Bacon O; Hogan LE; Rutishauser R; Hill A; Kearney MF; Anderson EM; Buchbinder SP; Cohen SE; Abdel-Mohsen M; Pohlmeyer CW; Fromentin R; Hoh R; Liu AY; McCune JM; Spindler J; Metcalf-Pate K; Hobbs KS; Thanh C; Gibson EA; Kuritzkes DR; Siliciano RF; Price RW; Richman DD; Chomont N; Siliciano JD; Mellors JW; Yukl SA; Blankson JN; Liegler T; Deeks SG
    PLoS Med; 2017 Nov; 14(11):e1002417. PubMed ID: 29112956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virologic failure is uncommon after treatment initiation during acute HIV infection.
    Crowell TA; Phanuphak N; Pinyakorn S; Kroon E; Fletcher JL; Colby D; Tipsuk S; Karnsomlap P; Laopraynak N; O'Connell RJ; Robb ML; Ananworanich J;
    AIDS; 2016 Jul; 30(12):1943-50. PubMed ID: 27163706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment.
    Edén A; Fuchs D; Hagberg L; Nilsson S; Spudich S; Svennerholm B; Price RW; Gisslén M
    J Infect Dis; 2010 Dec; 202(12):1819-25. PubMed ID: 21050119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation.
    Dahl V; Peterson J; Fuchs D; Gisslen M; Palmer S; Price RW
    AIDS; 2014 Sep; 28(15):2251-8. PubMed ID: 25022595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid HIV RNA in persons living with HIV.
    Di Carlofelice M; Everitt A; Muir D; Winston A
    HIV Med; 2018 May; 19(5):365-368. PubMed ID: 29368400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?
    Joseph SB; Trunfio M; Kincer LP; Calcagno A; Price RW
    AIDS; 2019 Dec; 33 Suppl 2():S171-S179. PubMed ID: 31790378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India.
    Dravid AN; Natrajan K; Kulkarni MM; Saraf CK; Mahajan US; Kore SD; Rathod NM; Mahajan US; Wadia RS
    Medicine (Baltimore); 2018 Feb; 97(8):e9969. PubMed ID: 29465595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.
    Peluso MJ; Ferretti F; Peterson J; Lee E; Fuchs D; Boschini A; Gisslén M; Angoff N; Price RW; Cinque P; Spudich S
    AIDS; 2012 Sep; 26(14):1765-74. PubMed ID: 22614889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission dynamics among participants initiating antiretroviral therapy upon diagnosis of early acute HIV-1 infection in Thailand.
    Kroon E; Pham PT; Sirivichayakul S; Trichavaroj R; Colby DJ; Pinyakorn S; Phanuphak N; Sanders-Buell E; van Griensven F; Kijak GH; Kim JH; Michael NL; Robb ML; Ananworanich J; De Souza MS; Tovanabutra S;
    AIDS; 2018 Oct; 32(16):2373-2381. PubMed ID: 30096068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.